John Armitage - Egerton Capital Holdings – 2025 Q3
Explore the latest portfolio disclosure for John Armitage - Egerton Capital, with insights into sector exposure, position sizes, and overall investment structure for 2025 Q3.
The latest 2025 Q3 filing shows that John Armitage - Egerton Capital maintains its largest exposure in Technology, which represents approximately 26.83% of the portfolio. This sector forms the core of John Armitage - Egerton Capital's investment stance during this reporting period.
Additional major allocations include Finance (about 26.71%) and Real Estate (approximately 12.28%), reflecting how John Armitage - Egerton Capital diversifies beyond its primary sector focus.
These sector weightings provide a clear view into John Armitage - Egerton Capital's positioning and conviction areas for the 2025 Q3 quarter.
Breakdown by Sector
| Symbol | Shares | Reported Price(USD) | Action | Change % | Portfolio Weight | Position Value | Filing Period |
|---|---|---|---|---|---|---|---|
| MSFT | 1,810,788 | $517.95 | Reduced | -1.80% | 9.89% | $937.9M | 2025 Q3 |
| AMZN | 4,053,249 | $219.57 | Increased | 21.45% | 9.39% | $889.97M | 2025 Q3 |
| V | 2,383,373 | $341.38 | Increased | 24.76% | 8.58% | $813.64M | 2025 Q3 |
| PGR | 2,588,638 | $246.95 | Reduced | -1.87% | 6.74% | $639.26M | 2025 Q3 |
| FERG | 2,600,224 | $224.58 | Increased | 16.43% | 6.16% | $583.96M | 2025 Q3 |
| BSX | 5,312,504 | $97.63 | Increased | 223.74% | 5.47% | $518.66M | 2025 Q3 |
| CRH | 4,260,846 | $119.9 | Reduced | -6.78% | 5.39% | $510.88M | 2025 Q3 |
| APH | 3,823,422 | $123.75 | Increased | 20.67% | 4.99% | $473.15M | 2025 Q3 |
| COF | 2,077,839 | $212.58 | Reduced | -10.96% | 4.66% | $441.71M | 2025 Q3 |
| IBKR | 6,254,134 | $68.81 | Reduced | -22.37% | 4.54% | $430.35M | 2025 Q3 |
| META | 541,167 | $734.38 | Reduced | -1.84% | 4.19% | $397.42M | 2025 Q3 |
| STX | 1,592,983 | $236.06 | Reduced | -22.35% | 3.97% | $376.04M | 2025 Q3 |
| FLUT | 1,412,018 | $254 | Reduced | -2.61% | 3.78% | $358.65M | 2025 Q3 |
| CRS | 1,374,333 | $245.54 | Reduced | -28.01% | 3.56% | $337.45M | 2025 Q3 |
| CME | 1,184,788 | $270.19 | Reduced | -22.20% | 3.38% | $320.12M | 2025 Q3 |
| ACGL | 3,507,882 | $90.73 | Reduced | -17.29% | 3.36% | $318.27M | 2025 Q3 |
| MA | 460,155 | $568.81 | Increased | 9.55% | 2.76% | $261.74M | 2025 Q3 |
| ICE | 1,036,199 | $168.48 | Reduced | -4.05% | 1.84% | $174.58M | 2025 Q3 |
| CP | 2,026,311 | $74.49 | Reduced | -55.54% | 1.59% | $150.94M | 2025 Q3 |
| EMBJ | 2,117,012 | $60.45 | Buy | 100.00% | 1.35% | $127.97M | 2025 Q3 |
| ARMK | 3,204,201 | $38.4 | Increased | 13.24% | 1.30% | $123.04M | 2025 Q3 |
| TRU | 1,465,050 | $83.78 | Buy | 100.00% | 1.29% | $122.74M | 2025 Q3 |
| LAMR | 723,857 | $122.42 | Buy | 100.00% | 0.93% | $88.61M | 2025 Q3 |
| FCNCA | 47,384 | $1789.17 | Reduced | -46.77% | 0.89% | $84.78M | 2025 Q3 |